- Global Pharma News & Resources

TransEnterix to Present at the 37th Annual J. P. Morgan Healthcare Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco, California. The presentation is scheduled to take place at 12:00 pm Pacific Time (3:00 pm Eastern Time), Monday, January 7, 2019.

A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s website at A replay of the webcast will be archived on the website for approximately 90 days.

About TransEnterix

TransEnterix is a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options in today's value-based healthcare environment. The Company is focused on the commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery. The system allows for robotic precision, haptic feedback, surgeon camera control via eye sensing and improved ergonomics while offering responsible economics. The Senhance Surgical System is available for sale in the US, the EU and select other countries. For more information, visit

View source version on

Editor Details

Last Updated: 20-Dec-2018